Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market.. View…
AVESTHAGEN obtains India patent for AVENT™ .. View More
AVESTHAGEN moves towards Clinicals of its biosimilar AVENT™ .. View More
Women are writing the entrepreneurship code in biotech.. View More
Vegan-friendly Muesli from ‘Good Earth’, All India.. View More